Heimli, Marte
Tennebø Flåm, Siri
Sagsveen Hjorthaug, Hanne
Bjørnstad, Pål Marius
Chernigovskaya, Maria
Le, Quy Khang
Tekpli, Xavier
Greiff, Victor
Lie, Benedicte Alexandra
Funding for this research was provided by:
Diabetesforbundet
Norges Forskningsråd (214280, 301536, 274718, 300740, 331890, 31341)
HORIZON EUROPE European Research Council (825821)
UiO: LifeScience Convergence Environment Immunolingo
Article History
Received: 30 March 2023
Accepted: 11 October 2023
First Online: 18 October 2023
Competing interests
: V.G. declares advisory board positions in aiNET GmbH, Enpicom B.V, Absci, Omniscope, and Diagonal Therapeutics. V.G. is a consultant for Adaptyv Biosystems, Specifica Inc, Roche/Genentech, immunai, and LabGenius. Remaining authors declare that they have no competing interest.